Pegasys 180 MCG in 1 ML Injection

RxCUI: 352297
RxNorm name: Pegasys 180 MCG in 1 ML Injection
Display name: Pegasys 180 MCG in 1 ML Injection
Full name: Pegasys 180 MCG in 1 ML Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:23

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
103964	Pegasys	peginterferon alfa-2a	351(a)	Rx	2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Pegasys	PEGINTERFERON ALFA-2A	pharmaand GmbH	d9290e5b-6d40-2318-e053-2995a90a9916	2026-09-02	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 352297

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
d9290e5b-6d40-2318-e053-2995a90a9916	Pegasys 180 MCG in 1 ML Injection [PSN] · 1 ML peginterferon alfa-2a 0.18 MG/ML Injection [Pegasys] [SBD] · 1 ML Pegasys 0.18 MG/ML Injection [SY] · Pegasys 0.18 MG/ML Injectable Solution [SY] · Pegasys 180 MCG/ML Injectable Solution [SY]	5	44	These highlights do not include all the information needed to use PEGASYS safely and effectively. See full prescribing information for PEGASYS. PEGASYS® (peginterferon alfa-2a) injection, for subcutaneous use Initial U.S. Approval: 2002	20250811